Increase in claudin-2 mediated by IL-6 is a known mechanism leading to epithelial disruption that is well-documented in animal models and in IBD patients, having been reported to be inhibited by AhR signaling [71,74,75,76]. Here, AHR is linked to inflammatory bowel disease.